Table 2. Outcomes for case-patients with CDI, Monroe County, New York, USA, March 1–August 31, 2008*.
| Characteristic | HCFO | CO-HCA | CA† | p value |
|---|---|---|---|---|
| Complications | ||||
| Hospitalized for CDI | NC | 39 (38) | 13 (19) | 0.02 |
| Median length of stay, d (SD) | NC | 7 (17) | 4 (11) | 0.06 |
| Outcome‡ | ||||
| Survived | 158 (80) | 89 (86) | 44 (66) | ND |
| Died | 23 (12) | 9 (9) | 0 (0) | ND |
| Unknown | 15 (8) | 5 (5) | 23 (34) | ND |
| Deaths caused by CDI | ||||
| Yes | 7/23 (30) | 3/9 (33) | NC | ND |
| No | 3/23(13) | 3/9 (33) | NC | ND |
| Unknown | 13/23 (57) | 3/9 (33) | NC | ND |
| Laboratory-confirmed recurrence (>1) | 43 (22) | 23 (22) | 8 (12) | 0.17 |
*Values are no. (%) positive or no. positive/no. tested (%) except as indicated. CDI, Clostridium difficile infection; HCFO, health care facility onset; CO-HCA, community onset–health care associated; CA, community associated; NC, not compared, ND, not determined. †Definite and probable CA cases. ‡For hospitalized patients, death occurred in the hospital. For nonhospitalized patients, death occurred 8 weeks after a positive C. difficile assay result.